Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib. [electronic resource]
- Haematologica May 2004
- ECR15 p. digital
Publication Type: Case Reports; Journal Article
1592-8721
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Benzamides Female Gene Rearrangement Genes, abl--genetics Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Middle Aged Piperazines--therapeutic use Protein Kinase Inhibitors--therapeutic use Proto-Oncogene Proteins c-bcr--genetics Pyrimidines--therapeutic use Remission Induction